Residency · Omaha, NE
Sponsored by University of Nebraska Medical Center College of Medicine
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.
The New England journal of medicine · 2021 · 8,425 citations · Brandon Essink, Adam Brosz
A Bivalent Omicron-Containing Booster Vaccine against Covid-19.
The New England journal of medicine · 2022 · 518 citations · Brandon Essink, Adam Brosz
Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase.
The New England journal of medicine · 2021 · 495 citations · Brandon Essink
Holistic evaluation of large language models for medical tasks with MedHELM.
Nature medicine · 2026 · 28 citations · Faraz Ghoddusi
Safety and Immunogenicity of mRNA-1010, an Investigational Seasonal Influenza Vaccine, in Healthy Adults: Final Results From a Phase 1/2 Randomized Trial.
The Journal of infectious diseases · 2025 · 48 citations · David Ensz
Pivotal Phase 3 Randomized Clinical Trial of the Safety, Tolerability, and Immunogenicity of 20-Valent Pneumococcal Conjugate Vaccine in Adults Aged ≥18 Years.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2022 · 134 citations · Brandon Essink
The safety and immunogenicity of two Zika virus mRNA vaccine candidates in healthy flavivirus baseline seropositive and seronegative adults: the results of two randomised, placebo-controlled, dose-ranging, phase 1 clinical trials.
The Lancet. Infectious diseases · 2023 · 123 citations · Brandon Essink
Safety and Immunogenicity of a Respiratory Syncytial Virus Prefusion F (RSVPreF3) Candidate Vaccine in Older Adults: Phase 1/2 Randomized Clinical Trial.
The Journal of infectious diseases · 2023 · 107 citations · Brandon Essink